Increasing drug development costs are leading to calls for more streamlined healthcare delivery. The use of real-world data resources can provide a clear way to achieve this and lead to improved patient outcomes. Aiden Flynn at Exploristics discusses how real-world patient data can be an invaluable asset in clinical development.